Shanghai Jiaoda Onlly Co Ltd

SHG:600530 China Drug Manufacturers - Specialty & Generic
Market Cap
$591.44 Million
CN¥4.34 Billion CNY
Market Cap Rank
#13304 Global
#3410 in China
Share Price
CN¥5.60
Change (1 day)
-1.58%
52-Week Range
CN¥4.28 - CN¥10.67
All Time High
CN¥10.67
Categories
Companies in China Drug Manufacturers - Specialty & Generic
About

Shanghai Jiaoda Onlly Co.,Ltd, together with its subsidiaries, engages in the research, development, and production of raw materials and end products of food and health food in China. It is also involved in the operation and management of elderly medical care institutions, including hospitals and nursing homes; and the provision of management consulting services to non-profit hospitals, nursing h… Read more

Shanghai Jiaoda Onlly Co Ltd (600530) - Net Assets

Latest net assets as of September 2025: CN¥371.55 Million CNY

Based on the latest financial reports, Shanghai Jiaoda Onlly Co Ltd (600530) has net assets worth CN¥371.55 Million CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥733.99 Million) and total liabilities (CN¥362.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥371.55 Million
% of Total Assets 50.62%
Annual Growth Rate 3.03%
5-Year Change -57.0%
10-Year Change -80.87%
Growth Volatility 79.43

Shanghai Jiaoda Onlly Co Ltd - Net Assets Trend (1998–2024)

This chart illustrates how Shanghai Jiaoda Onlly Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Shanghai Jiaoda Onlly Co Ltd (1998–2024)

The table below shows the annual net assets of Shanghai Jiaoda Onlly Co Ltd from 1998 to 2024.

Year Net Assets Change
2024-12-31 CN¥375.21 Million +10.62%
2023-12-31 CN¥339.18 Million -8.40%
2022-12-31 CN¥370.29 Million -59.47%
2021-12-31 CN¥913.57 Million +4.69%
2020-12-31 CN¥872.63 Million +10.16%
2019-12-31 CN¥792.15 Million -19.42%
2018-12-31 CN¥983.07 Million -43.71%
2017-12-31 CN¥1.75 Billion -1.33%
2016-12-31 CN¥1.77 Billion -9.75%
2015-12-31 CN¥1.96 Billion -11.55%
2014-12-31 CN¥2.22 Billion +51.95%
2013-12-31 CN¥1.46 Billion -4.36%
2012-12-31 CN¥1.53 Billion +8.06%
2011-12-31 CN¥1.41 Billion +27.40%
2010-12-31 CN¥1.11 Billion +20.28%
2009-12-31 CN¥921.58 Million -5.65%
2008-12-31 CN¥976.75 Million -14.86%
2007-12-31 CN¥1.15 Billion +4.55%
2006-12-31 CN¥1.10 Billion +1.88%
2005-12-31 CN¥1.08 Billion +2.43%
2004-12-31 CN¥1.05 Billion +3.26%
2003-12-31 CN¥1.02 Billion +11.00%
2002-12-31 CN¥917.46 Million +1.90%
2001-12-31 CN¥900.32 Million +398.25%
2000-12-31 CN¥180.69 Million -10.17%
1999-12-31 CN¥201.14 Million +16.58%
1998-12-31 CN¥172.53 Million --

Equity Component Analysis

This analysis shows how different components contribute to Shanghai Jiaoda Onlly Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 5810.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock CN¥774.92 Million 237.92%
Other Comprehensive Income CN¥163.04 Million 50.06%
Other Components CN¥33.63 Million 10.32%
Total Equity CN¥325.71 Million 100.00%

Shanghai Jiaoda Onlly Co Ltd Competitors by Market Cap

The table below lists competitors of Shanghai Jiaoda Onlly Co Ltd ranked by their market capitalization.

Company Market Cap
Real Matters Inc
PINK:RLLMF
 		$274.55 Million
Liuzhou Liangmianzhen Co Ltd
SHG:600249
 		$274.59 Million
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
 		$274.67 Million
Timberland Bancorp Inc
NASDAQ:TSBK
 		$274.80 Million
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
 		$274.51 Million
Aeolus Tyre Co Ltd
SHG:600469
 		$274.37 Million
Qingdao Weflo Valve Co Ltd
SHE:002871
 		$274.36 Million
Capital A Berhad
KLSE:5099
 		$274.34 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shanghai Jiaoda Onlly Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 294,789,513 to 325,711,012, a change of 30,921,499 (10.5%).
  • Net income of 30,481,364 contributed positively to equity growth.
  • Dividend payments of 1,852,949 reduced retained earnings.
  • Other comprehensive income increased equity by 141,554,681.
  • Other factors decreased equity by 139,261,597.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥30.48 Million +9.36%
Dividends Paid CN¥1.85 Million -0.57%
Other Comprehensive Income CN¥141.55 Million +43.46%
Other Changes CN¥-139.26 Million -42.76%
Total Change CN¥- 10.49%

Book Value vs Market Value Analysis

This analysis compares Shanghai Jiaoda Onlly Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.10x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 25.73x to 13.10x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-12-31 CN¥0.22 CN¥5.60 x
1999-12-31 CN¥0.25 CN¥5.60 x
2000-12-31 CN¥0.23 CN¥5.60 x
2001-12-31 CN¥1.14 CN¥5.60 x
2002-12-31 CN¥1.15 CN¥5.60 x
2003-12-31 CN¥1.22 CN¥5.60 x
2004-12-31 CN¥1.21 CN¥5.60 x
2005-12-31 CN¥1.22 CN¥5.60 x
2006-12-31 CN¥1.23 CN¥5.60 x
2007-12-31 CN¥1.57 CN¥5.60 x
2008-12-31 CN¥1.02 CN¥5.60 x
2009-12-31 CN¥1.11 CN¥5.60 x
2010-12-31 CN¥1.39 CN¥5.60 x
2011-12-31 CN¥1.74 CN¥5.60 x
2012-12-31 CN¥1.89 CN¥5.60 x
2013-12-31 CN¥1.70 CN¥5.60 x
2014-12-31 CN¥2.67 CN¥5.60 x
2015-12-31 CN¥2.35 CN¥5.60 x
2016-12-31 CN¥2.14 CN¥5.60 x
2017-12-31 CN¥2.10 CN¥5.60 x
2018-12-31 CN¥1.16 CN¥5.60 x
2019-12-31 CN¥0.97 CN¥5.60 x
2020-12-31 CN¥1.08 CN¥5.60 x
2021-12-31 CN¥1.13 CN¥5.60 x
2022-12-31 CN¥0.42 CN¥5.60 x
2023-12-31 CN¥0.42 CN¥5.60 x
2024-12-31 CN¥0.43 CN¥5.60 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shanghai Jiaoda Onlly Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 9.36%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 9.37%
  • • Asset Turnover: 0.43x
  • • Equity Multiplier: 2.33x
  • Recent ROE (9.36%) is above the historical average (-1.94%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 30.14% 13.84% 1.01x 2.16x CN¥34.23 Million
1999 30.27% 11.55% 1.15x 2.27x CN¥39.99 Million
2000 28.09% 10.56% 1.07x 2.49x CN¥32.60 Million
2001 6.14% 12.05% 0.39x 1.32x CN¥-34.32 Million
2002 5.69% 10.73% 0.36x 1.49x CN¥-38.69 Million
2003 5.96% 8.94% 0.40x 1.68x CN¥-38.63 Million
2004 3.29% 4.19% 0.49x 1.59x CN¥-63.49 Million
2005 3.27% 8.89% 0.19x 1.98x CN¥-64.12 Million
2006 4.17% 7.95% 0.29x 1.79x CN¥-56.19 Million
2007 0.51% 0.90% 0.34x 1.67x CN¥-95.45 Million
2008 -17.63% -42.10% 0.20x 2.12x CN¥-219.53 Million
2009 3.20% 8.41% 0.28x 1.36x CN¥-56.44 Million
2010 5.48% 17.11% 0.26x 1.24x CN¥-47.88 Million
2011 4.08% 15.84% 0.21x 1.24x CN¥-80.56 Million
2012 5.65% 22.16% 0.20x 1.26x CN¥-63.90 Million
2013 6.27% 22.61% 0.20x 1.35x CN¥-49.46 Million
2014 4.07% 21.85% 0.14x 1.33x CN¥-123.64 Million
2015 5.41% 37.00% 0.10x 1.47x CN¥-84.11 Million
2016 8.24% 51.04% 0.11x 1.48x CN¥-29.40 Million
2017 9.82% 56.88% 0.12x 1.38x CN¥-2.99 Million
2018 -56.03% -194.58% 0.18x 1.59x CN¥-596.36 Million
2019 -9.41% -20.70% 0.24x 1.88x CN¥-146.08 Million
2020 10.72% 26.91% 0.26x 1.55x CN¥6.04 Million
2021 4.24% 10.25% 0.27x 1.54x CN¥-50.41 Million
2022 -151.47% -132.15% 0.43x 2.69x CN¥-531.33 Million
2023 -11.90% -11.84% 0.36x 2.77x CN¥-64.56 Million
2024 9.36% 9.37% 0.43x 2.33x CN¥-2.09 Million

Industry Comparison

This section compares Shanghai Jiaoda Onlly Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $5,061,893,866
  • Average return on equity (ROE) among peers: 4.12%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shanghai Jiaoda Onlly Co Ltd (600530) CN¥371.55 Million 30.14% 0.98x $274.52 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078) $2.84 Billion -41.97% 9.13x $608.50 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.29 Billion 4.72% 1.33x $324.94 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $11.33 Billion 18.40% 0.22x $3.03 Billion
Wedge Industrial Co Ltd (000534) $1.30 Billion 13.53% 1.39x $1.92 Billion
Yunnan Baiyao Group Co Ltd (000538) $525.21 Million 17.84% 0.75x $5.59 Billion
Hainan Haiyao Co Ltd (000566) $4.63 Billion -3.44% 1.33x $704.71 Million
Tus Pharmaceutical Group Co Ltd (000590) $268.78 Million 10.37% 0.50x $325.99 Million
Northeast Pharmaceutical Group Co Ltd (000597) $2.07 Billion 2.59% 1.71x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $22.44 Billion 6.25% 0.15x $2.04 Billion
Renhe Pharmacy Co Ltd (000650) $3.91 Billion 12.94% 0.18x $777.45 Million